They have answered this multiple times and wouldn’t directly disclose if a cap raise is coming? Obviously market sensitive
If you read prior posts or did some research you would know that they are not looking to cause unnecessary dilution to funds that will dump on the market for a 5% gain. Any future funding for trials will likely be on a partnership basis in my opinion, which reduces the need for a cap raise. Partnerships and use of other non dilutive sources of funding have been well discussed on this forum.
They have answered this multiple times and wouldn’t directly...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.030(2.52%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.16 | $78.70K | 66.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 4561 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
0.030 ( 0.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.19 | $1.22 | $1.16 | 11297 | ||
| Last updated 15.56pm 07/05/2024 ? | |||||
| RAC (ASX) Chart |